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EditorialsUpdate on the cardiovascular and thoracic service-line concept
Lawrence H. Cohn, MD
As readers of the Journal, you might recall that in my edito-
rials of January and July, I discussed expanding the service-
line concept among the articles and subjects printed in the
Journal. A new feature of the Journal recently introduced
is the summary of important meeting proceedings. In the
July issue of the Journal, the highlights of the Annual Amer-
ican College of Cardiology meeting were summarized, high-
lighting important new trials that many in our field might not
be familiar with but might become increasingly important to
their day-to-day practice. The October issue highlighted the
International Society for Minimally Invasive Cardiothoracic
Surgery meeting in Boston, providing insight into new tech-
niques and technology in minimally invasive cardiothoracic
surgery. In subsequent issues we plan to highlight other im-
portant meetings, including the Transcatheter Cardiovascu-
lar Therapeutics meeting, the American Heart Association
meeting, and important oncology meetings for general tho-
racic surgeons. We hope our readership finds these summa-
ries to be a natural extension of our service-line concept,
keeping all of us abreast of the important issues of our com-
bined specialties and integrating research, clinical, and aca-
demic efforts with our nonsurgical colleagues in these areas.
In this regard a current trial that I believe is important to
understand is the SYNTAX trial, which was reported at
the European College of Cardiology in Munich, Germany,
this past summer. This trial was a randomized, controlled,
multicenterAmerican/European trial comparing percutaneous
coronary intervention (PCI) with drug-eluting stents with
coronary artery bypass grafting (CABG) in patients with
left main and 3-vessel disease. All patients in this trial were
determined to be eligible for either therapy by a team of car-
diologists and cardiac surgeons. The stent group received an
average of 4.6 stents per patient, and the CABG group
received an average of 3.2 grafts per patient. The early
combined death, stroke, and myocardial infarction rate was
7.6% for the PCI group and 7.7% for the CABG group
and was not statistically significant. However, the stroke
rate in the CABG group was 2.2% versus 0.6% for the
PCI group. Most importantly, the overall 12-month major
adverse cardiovascular and cerebral vascular event rate was
significantly higher in the PCI group (17.8% vs 12% in
the CABG group, P¼ .0015). This is an interesting and sig-
nificant study and one I believe we will be hearing about for
many months to come. The results of this trial are important
and should be brought to the attention of practicing adult car-
diac surgeons, allowing us to keep up, stay ahead, and, most
importantly, stay informed.
You will continue to see increased collaboration in our
specialty from all specialists, and we will continue to report
important cardiac and thoracic trials in the pages of the Jour-
nal. We would like feedback from our readership if they
believe this kind of activity is important and should be
expanded to include other meetings and trials.
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